Paul A Fedalen, MD - Medicare Cardiac Surgery in Dover, DE

Paul A Fedalen, MD is a medicare enrolled "Thoracic Surgery (cardiothoracic Vascular Surgery)" physician in Dover, Delaware. He went to Perelman School Of Med At The University Of Pennsylvania and graduated in 1994 and has 30 years of diverse experience with area of expertise as Cardiac Surgery. He is a member of the group practice Bayhealth Medical Center, Inc and his current practice location is 540 S Governors Ave Ste 101a, Dover, Delaware. You can reach out to his office (for appointments etc.) via phone at (302) 744-7980.

Paul A Fedalen is licensed to practice in Delaware (license number C1-0007342) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1538151741.

Contact Information

Paul A Fedalen, MD
540 S Governors Ave Ste 101a,
Dover, DE 19904-3530
(302) 744-7980
(302) 744-7989



Physician's Profile

Full NamePaul A Fedalen
GenderMale
SpecialityCardiac Surgery
Experience30 Years
Location540 S Governors Ave Ste 101a, Dover, Delaware
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Paul A Fedalen attended and graduated from Perelman School Of Med At The University Of Pennsylvania in 1994
  NPI Data:
  • NPI Number: 1538151741
  • Provider Enumeration Date: 08/16/2005
  • Last Update Date: 10/01/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 0446200208
  • Enrollment ID: I20050128000680

Medical Identifiers

Medical identifiers for Paul A Fedalen such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1538151741NPI-NPPES
1000032899MedicaidDE

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208G00000XThoracic Surgery (cardiothoracic Vascular Surgery) C1-0007342 (Delaware)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Bayhealth Hospital, Kent CampusDover, DEHospital
Bayhealth Hospital, Sussex CampusMilford, DEHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Bayhealth Medical Center, Inc1658364740288

News Archive

‘Into the Covid ICU': A new doctor bears witness to the isolation, inequities of pandemic

This week marks a grim milestone: Half a million Americans have died of Covid-19. KHN reporter Jenny Gold, in collaboration with Reveal from the Center for Investigative Reporting and PRX, spent eight months following one first-year medical resident working on the front lines of the pandemic.

Mini transplant patients' outcomes similar using related and unrelated donor cells

People who undergo nonmyeloablative stem-cell transplants, or "mini transplants," for leukemia, lymphoma and other blood cancers have comparable outcomes regardless of whether they receive tissue-matched stem cells from a related or unrelated donor, according to new findings by researchers at Fred Hutchinson Cancer Research Center.

Sermo announces a new report on evolving trends in CML

Sermo, the world's largest online community for physicians, today announced a Sermo Event™ Report titled "Evolving Trends in CML." The new report measures the impact of ENESTnd trial data on Oncologists' use of Tasigna (Novartis), Sprycel (Bristol Myers-Squibb) and Gleevec (Novartis) in newly diagnosed CML patients and assesses overall trends in CML monitoring and management. While Gleevec will likely remain the #1 treatment, there will be a close race for the runner-up spot amongst second-generation tyrosine kinase inhibitors in the front line setting.

LSTM researchers show potential of novel antiparasitic drug to combat malaria

Researchers from the Liverpool School of Tropical Medicine have shown the large potential impact of a completely new type of antimalarial drug that kills mosquitoes, as opposed to existing drugs that target the parasite, to reduce the spread of malaria.

Study identifies tumor cell population responsible for resistance to therapy and cancer relapse

Resistance to therapy is a major problem in cancer patients as the cells that resist to therapy is at the root of tumor relapse and is associated with high morbidity and mortality.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Paul A Fedalen allows following entities to bill medicare on his behalf.
Entity NameBayhealth Medical Center, Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1467546135
PECOS PAC ID: 1658364740
Enrollment ID: O20040405001600

News Archive

‘Into the Covid ICU': A new doctor bears witness to the isolation, inequities of pandemic

This week marks a grim milestone: Half a million Americans have died of Covid-19. KHN reporter Jenny Gold, in collaboration with Reveal from the Center for Investigative Reporting and PRX, spent eight months following one first-year medical resident working on the front lines of the pandemic.

Mini transplant patients' outcomes similar using related and unrelated donor cells

People who undergo nonmyeloablative stem-cell transplants, or "mini transplants," for leukemia, lymphoma and other blood cancers have comparable outcomes regardless of whether they receive tissue-matched stem cells from a related or unrelated donor, according to new findings by researchers at Fred Hutchinson Cancer Research Center.

Sermo announces a new report on evolving trends in CML

Sermo, the world's largest online community for physicians, today announced a Sermo Event™ Report titled "Evolving Trends in CML." The new report measures the impact of ENESTnd trial data on Oncologists' use of Tasigna (Novartis), Sprycel (Bristol Myers-Squibb) and Gleevec (Novartis) in newly diagnosed CML patients and assesses overall trends in CML monitoring and management. While Gleevec will likely remain the #1 treatment, there will be a close race for the runner-up spot amongst second-generation tyrosine kinase inhibitors in the front line setting.

LSTM researchers show potential of novel antiparasitic drug to combat malaria

Researchers from the Liverpool School of Tropical Medicine have shown the large potential impact of a completely new type of antimalarial drug that kills mosquitoes, as opposed to existing drugs that target the parasite, to reduce the spread of malaria.

Study identifies tumor cell population responsible for resistance to therapy and cancer relapse

Resistance to therapy is a major problem in cancer patients as the cells that resist to therapy is at the root of tumor relapse and is associated with high morbidity and mortality.

Read more Medical News

› Verified 7 days ago

Entity NameBayhealth Medical Center, Inc
Entity TypePart B Supplier - Hospital Department(s)
Entity IdentifiersNPI Number: 1023006434
PECOS PAC ID: 1658364740
Enrollment ID: O20160527000094

News Archive

‘Into the Covid ICU': A new doctor bears witness to the isolation, inequities of pandemic

This week marks a grim milestone: Half a million Americans have died of Covid-19. KHN reporter Jenny Gold, in collaboration with Reveal from the Center for Investigative Reporting and PRX, spent eight months following one first-year medical resident working on the front lines of the pandemic.

Mini transplant patients' outcomes similar using related and unrelated donor cells

People who undergo nonmyeloablative stem-cell transplants, or "mini transplants," for leukemia, lymphoma and other blood cancers have comparable outcomes regardless of whether they receive tissue-matched stem cells from a related or unrelated donor, according to new findings by researchers at Fred Hutchinson Cancer Research Center.

Sermo announces a new report on evolving trends in CML

Sermo, the world's largest online community for physicians, today announced a Sermo Event™ Report titled "Evolving Trends in CML." The new report measures the impact of ENESTnd trial data on Oncologists' use of Tasigna (Novartis), Sprycel (Bristol Myers-Squibb) and Gleevec (Novartis) in newly diagnosed CML patients and assesses overall trends in CML monitoring and management. While Gleevec will likely remain the #1 treatment, there will be a close race for the runner-up spot amongst second-generation tyrosine kinase inhibitors in the front line setting.

LSTM researchers show potential of novel antiparasitic drug to combat malaria

Researchers from the Liverpool School of Tropical Medicine have shown the large potential impact of a completely new type of antimalarial drug that kills mosquitoes, as opposed to existing drugs that target the parasite, to reduce the spread of malaria.

Study identifies tumor cell population responsible for resistance to therapy and cancer relapse

Resistance to therapy is a major problem in cancer patients as the cells that resist to therapy is at the root of tumor relapse and is associated with high morbidity and mortality.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Paul A Fedalen is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Paul A Fedalen, MD
640 S. State Street, Mail Code 3055,
Dover, DE 19901

Ph: (302) 480-1688
Paul A Fedalen, MD
540 S Governors Ave Ste 101a,
Dover, DE 19904-3530

Ph: (302) 744-7980

News Archive

‘Into the Covid ICU': A new doctor bears witness to the isolation, inequities of pandemic

This week marks a grim milestone: Half a million Americans have died of Covid-19. KHN reporter Jenny Gold, in collaboration with Reveal from the Center for Investigative Reporting and PRX, spent eight months following one first-year medical resident working on the front lines of the pandemic.

Mini transplant patients' outcomes similar using related and unrelated donor cells

People who undergo nonmyeloablative stem-cell transplants, or "mini transplants," for leukemia, lymphoma and other blood cancers have comparable outcomes regardless of whether they receive tissue-matched stem cells from a related or unrelated donor, according to new findings by researchers at Fred Hutchinson Cancer Research Center.

Sermo announces a new report on evolving trends in CML

Sermo, the world's largest online community for physicians, today announced a Sermo Event™ Report titled "Evolving Trends in CML." The new report measures the impact of ENESTnd trial data on Oncologists' use of Tasigna (Novartis), Sprycel (Bristol Myers-Squibb) and Gleevec (Novartis) in newly diagnosed CML patients and assesses overall trends in CML monitoring and management. While Gleevec will likely remain the #1 treatment, there will be a close race for the runner-up spot amongst second-generation tyrosine kinase inhibitors in the front line setting.

LSTM researchers show potential of novel antiparasitic drug to combat malaria

Researchers from the Liverpool School of Tropical Medicine have shown the large potential impact of a completely new type of antimalarial drug that kills mosquitoes, as opposed to existing drugs that target the parasite, to reduce the spread of malaria.

Study identifies tumor cell population responsible for resistance to therapy and cancer relapse

Resistance to therapy is a major problem in cancer patients as the cells that resist to therapy is at the root of tumor relapse and is associated with high morbidity and mortality.

Read more News

› Verified 7 days ago


Thoracic Surgery (Cardiothoracic Vascular Surgery) Doctors in Dover, DE

Gary Walter Szydlowski, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery)
Medicare: Accepting Medicare Assignments
Practice Location: 540 S Governors Ave Ste 101a, Dover, DE 19904
Phone: 302-744-7980    Fax: 302-744-7989
Dr. Daniel Marelli, M.D.
Thoracic Surgery (Cardiothoracic Vascular Surgery)
Medicare: Accepting Medicare Assignments
Practice Location: 540 S Governors Ave Ste 101a, Dover, DE 19904
Phone: 302-744-7980    Fax: 302-744-7989
John Dana Mannion, M.D.
Thoracic Surgery (Cardiothoracic Vascular Surgery)
Medicare: Not Enrolled in Medicare
Practice Location: 540 S Governors Ave, Suite 101a, Dover, DE 19904
Phone: 302-744-7980    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.